Same Indication

Nivolumab vs Tramadol

Nivolumab vs Tramadol: Overview

This comparison examines the pharmacological differences between Nivolumab and Tramadol.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Tramadol: Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Tramadol — 5-7 hours.

Chemical Properties

Molecular Formula: Tramadol — C16H25NO2.

Molecular Weight: Tramadol — 263.3750 g/mol.

Type: Nivolumab — Antibody; Tramadol — Small molecule.